Search research articles
Contact Us
Filters
Showing results (81-90 of 107) with videos related to
Page
of 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
Ilaria Colombo, Sofia Genta, Federica Martorana, et al.
Frontiers in Pharmacology
|
August 21, 2025
Pragmatic and contextualized methods selection for safety assessment of infant systemic exposure through human milk: the Milk4baby decision tree approach - a contribution from the concePTION project
Anaëlle Monfort, Julia Macente, Martje Van Neste, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study
Jérémie Tachet, Sara C Meyer, Francesco Grandoni, et al.
Clinical Pharmacokinetics
|
February 2, 2013
Population pharmacokinetic study of memantine: effects of clinical and genetic factors
Muriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Malaria Journal
|
July 12, 2013
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
Eva Maria Staehli Hodel, Monia Guidi, Boris Zanolari, et al.
Clinical Therapeutics
|
July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients
Evelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
BMC Pharmacology & Toxicology
|
July 7, 2026
Optimizing imatinib sampling strategies through a population approach: a crucial step to model-informed precision dosing validation for point-of-care therapeutic drug monitoring
Yuan J Pétermann, Junrui Chen, Lavinia Alberi, et al.
Journal of Clinical Pharmacology
|
May 30, 2024
Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use
Kim Dao, Michael Buettcher, Klervi Golhen, et al.
British Journal of Clinical Pharmacology
|
January 18, 2014
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance
Muriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
JCO Clinical Cancer Informatics
|
May 5, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging
Daniel Abler, Perrine Courlet, Matthieu Dietz, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 107) with videos related to
Sort By:
Page
of 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 16, 2021
Phase I Dose-Escalation Study of the Dual PI3K-mTORC1/2 Inhibitor Gedatolisib in Combination with Paclitaxel and Carboplatin in Patients with Advanced Solid Tumors
Ilaria Colombo, Sofia Genta, Federica Martorana, et al.
Frontiers in Pharmacology
|
August 21, 2025
Pragmatic and contextualized methods selection for safety assessment of infant systemic exposure through human milk: the Milk4baby decision tree approach - a contribution from the concePTION project
Anaëlle Monfort, Julia Macente, Martje Van Neste, et al.
Clinical Pharmacology and Therapeutics
|
June 24, 2026
Ruxolitinib Pharmacokinetics and Exposure-Toxicity Relationship in Hematologic Malignancies and Immune-Mediated Diseases: A Prospective Observational Study
Jérémie Tachet, Sara C Meyer, Francesco Grandoni, et al.
Clinical Pharmacokinetics
|
February 2, 2013
Population pharmacokinetic study of memantine: effects of clinical and genetic factors
Muriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
Malaria Journal
|
July 12, 2013
Population pharmacokinetics of mefloquine, piperaquine and artemether-lumefantrine in Cambodian and Tanzanian malaria patients
Eva Maria Staehli Hodel, Monia Guidi, Boris Zanolari, et al.
Clinical Therapeutics
|
July 8, 2020
Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients
Evelina Cardoso, Monia Guidi, Nihel Khoudour, et al.
BMC Pharmacology & Toxicology
|
July 7, 2026
Optimizing imatinib sampling strategies through a population approach: a crucial step to model-informed precision dosing validation for point-of-care therapeutic drug monitoring
Yuan J Pétermann, Junrui Chen, Lavinia Alberi, et al.
Journal of Clinical Pharmacology
|
May 30, 2024
Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use
Kim Dao, Michael Buettcher, Klervi Golhen, et al.
British Journal of Clinical Pharmacology
|
January 18, 2014
Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance
Muriel Noetzli, Monia Guidi, Karsten Ebbing, et al.
JCO Clinical Cancer Informatics
|
May 5, 2023
Semiautomated Pipeline to Quantify Tumor Evolution From Real-World Positron Emission Tomography/Computed Tomography Imaging
Daniel Abler, Perrine Courlet, Matthieu Dietz, et al.
Page
of 11